Reversible and irreversible inhibitors of coronavirus Nsp15 endoribonuclease

The emergence of severe acute respiratory syndrome coronavirus 2, the causative agent of coronavirus disease 2019, has resulted in the largest pandemic in recent history. Current therapeutic strategies to mitigate this disease have focused on the development of vaccines and on drugs that inhibit the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jerry, Farraj, Rabih Abou, Limonta, Daniel, Tabatabaei Dakhili, Seyed Amir, Kerek, Evan M., Bhattacharya, Ashim, Reformat, Filip M., Mabrouk, Ola M., Brigant, Benjamin, Pfeifer, Tom A., McDermott, Mark T., Ussher, John R., Hobman, Tom C., Glover, J.N. Mark, Hubbard, Basil P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656235/
https://www.ncbi.nlm.nih.gov/pubmed/37832873
http://dx.doi.org/10.1016/j.jbc.2023.105341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656235/
https://www.ncbi.nlm.nih.gov/pubmed/37832873
http://dx.doi.org/10.1016/j.jbc.2023.105341

Ejemplares similares